Listen "Novel Glaucoma Medications: From Clinical Trials to Clinical Experience"
Episode Synopsis
Vladislav P. Bekerman, MD, MBA, an ophthalmology resident at Rutgers New Jersey Medical School, offers insight into the use of new treatments as additive therapies for IOP reduction, as featured in an article by Bekerman and Albert S. Khouri, MD, in the January/February 2021 issue of Glaucoma Today.
More episodes of the podcast GT: The Podcast
The Role of Anterior Segment OCT in MIGS
22/08/2025
A Cilioscleral Interpositioning Device
28/07/2025
Metabolic Dysfunction in Glaucoma
28/04/2025